ApoB + lipid panel collection and reporting — Framingham, MA.

Framingham, MA is the literal birthplace of cardiovascular risk-factor epidemiology: the Framingham Heart Study, begun here in 1948 with 5,209 enrolled residents, published the finding in 1961 that elevated cholesterol carried more than a 3-fold increase in coronary heart disease risk in men and a 1.6-fold increase in women — the study that coined the term 'risk factor' itself (Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J III. Ann Intern Med. 1961;55:33-50). A measured apoB + lipid panel gives a Framingham resident the same class of marker their own city's namesake cohort has tracked for over 75 years.

Where

Accredited lab / clinic draw, Framingham, MA · Open the map

Pay

$440 proposed

This packet is not funded yet, so this figure is a proposed price and not money waiting in escrow. If a buyer funds it, approved proof settles that price onchain. If nobody funds it, approved proof earns provable credit toward the work instead of cash — recorded, and readable any time at vealth.net/labor/credit/(your wallet). You see which before you claim, never after.

Proof

Accredited-lab apoB + full lipid panel with reference ranges + fasting state noted + comparison to a risk-appropriate target band, with NO treatment recommendation

This is exactly what gets it approved. Nothing settles without it.

Level

intermediate

Open until

2026-10-31

Posted by

0x034F…6c89

The creator wallet. Its signature is what approves proof and settles the wage.

How this work is done

A documented method, so this packet comes out the same whoever does it.

Bring

• accredited-lab requisition or clinic draw (ApoB, LDL-C, HDL-C, triglycerides, total cholesterol; non-fasting acceptable for ApoB/LDL)
• chain-of-custody label
• prior results for trend if available

Steps

1. 1. Arrange the draw through an accredited lab or clinic (this is a specimen-collection + reporting packet, not a home guess).
2. 2. Record whether the sample was fasting or non-fasting (ApoB and LDL-C are valid non-fasting; triglycerides prefer fasting).
3. 3. Capture the reported ApoB (mg/dL), LDL-C, HDL-C, triglycerides, and total cholesterol with the lab's reference ranges.
4. 4. Place ApoB against risk-stratified targets (roughly: general <90 mg/dL, higher-risk <65-80 mg/dL per clinician).
5. 5. Note any discordance between LDL-C and ApoB (ApoB is the tiebreaker for particle burden).
6. 6. Attach the lab report; log values, units, fasting state, and the target band; sign it. Do NOT recommend or change any medication.

What counts as done

• ApoB (mg/dL) plus LDL-C, HDL-C, triglycerides, total cholesterol from an accredited lab with reference ranges
• Fasting/non-fasting state recorded
• Attached lab report; values compared to the general-population target band with no medication guidance

Proof is measured against these, not judged by taste.